ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Abzena, BioXpress Therapeutics Enter Biosimilar Tie-up
July 30, 2021Abzena, a provider of solutions for biologics and bioconjugates, and BioXpress Therapeutics, a developer of monoclonal antibody (mAb) biosimilar therapeutics, have partnered to support biosimilar development for third party customers. -
Abzena and BioXpress Therapeutics announce partnership to support the development and manufacture of biosimilars for global customers.
July 28, 2021Abzena, a Global Partner Research Organization for integrated bench to patient solutions for biologics and bioconjugates, and BioXpress Therapeutics, a world-class leading developer of high quality, monoclonal antibody (mAb) biosimilar therapeutics
Pharma Sources Insight January 2025
